Clinical Trial Record

Return to Clinical Trials

Post-operative Drainage After Pancreaticoduodenectomy


2016-05-01


2024-12-31


2025-03-31


300

Study Overview

Post-operative Drainage After Pancreaticoduodenectomy

The study compares regular use of surgical drains and no use of surgical drains in patients subjected to pancreaticoduodenectomy with expected low to intermediate risk for post operative pancreatic fistula.

N/A

  • Pancreatic Cancer
  • PROCEDURE: Drain
  • PROCEDURE: No drain
  • Drain_1

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2022-02-16  

N/A  

2022-03-07  

2022-03-07  

N/A  

2022-03-08  

2022-03-08  

N/A  

2022-02  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
Treatment


Allocation:
Randomized


Interventional Model:
Parallel


Masking:
None


Arms and Interventions

Participant Group/ArmIntervention/Treatment
ACTIVE_COMPARATOR: Drain

Surgical drains used as routine

PROCEDURE: Drain

  • Surgical drains are placed as a standard of care (control arm) or not (experimental arm)

PROCEDURE: No drain

  • Surgical drains are placed as a standard of care (control arm) or not (experimental arm)
EXPERIMENTAL: No drain

No surgical drain used

PROCEDURE: No drain

  • Surgical drains are placed as a standard of care (control arm) or not (experimental arm)
Primary Outcome MeasuresMeasure DescriptionTime Frame
Overall morbidity ratePost operative morbidity90 days post operatively
Secondary Outcome MeasuresMeasure DescriptionTime Frame
Mortality rate (in-hospital, 30 and 90 days)90 days post operatively
Severe morbidity rate as classified by Clavien-Dindo >390 days post operatively
Fistula rate according to ISGPF90 days post operatively
Intraabdominal abscess rate90 days post operatively
Wound infection rate90 days post operatively
Delayed gastric emptying according to ISGPF90 days post operatively
Postpancreatectomy bleeding according to ISGPF90 days post operatively
Need of interventional radiology90 days post operatively
Need for reoperation90 days post operatively
Hospital stay90 days post operatively
Readmission rate90 days post operatively

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Name: Bergthor Björnsson

Phone Number: +46703766890

Email: bergthor.bjornsson@liu.se

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:

    Inclusion Criteria:

  • Patients undergoing pancreaticoduodenectomy of both sexes
  • Patients with predicted risk score of 10 or less of pancreatic fistula
  • Written informed consent
  • Expected survival time > 6 months

  • Exclusion Criteria:

  • Patients with predicted high risk of fistula with a risk score above 10
  • Patients with intraabdominal abscess or infection
  • ASA score > 3
  • Pregnancy
  • Expected lack of compliance

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

  • Lund University

  • PRINCIPAL_INVESTIGATOR: Bergthor Björnsson, Linkoeping University

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

No publications available